Exp Clin Endocrinol Diabetes 2018; 126(08): 528-533
DOI: 10.1055/s-0044-101141
Article
© Georg Thieme Verlag KG Stuttgart · New York

Anti-Mullerian Hormone and Inhibin B Levels in Obese Boys; Relations with Cardiovascular Risk Factors

Muammer Buyukinan
1   Department of Pediatric Endocrinology, Konya Training and Research Hospital, Konya, Turkey
,
Muge Atar
2   Department of Pediatric Endocrinology and Diabetes, Suleyman Demirel University, Faculty of Medicine, Isparta, Turkey
,
Ozgur Pirgon
2   Department of Pediatric Endocrinology and Diabetes, Suleyman Demirel University, Faculty of Medicine, Isparta, Turkey
,
Huseyin Kurku
3   Department of Biochemistry, Konya Training and Research Hospital, Konya, Turkey
,
S. Sami Erdem
3   Department of Biochemistry, Konya Training and Research Hospital, Konya, Turkey
,
Isa Deniz
4   Department of Radiology, Konya Training and Research Hospital, Konya, Turkey
› Author Affiliations
Further Information

Publication History

received 29 October 2017
revised 14 January 2018

accepted 17 January 2018

Publication Date:
29 January 2018 (online)

Abstract

Objective Obesity may reduce sertoli cell functions in men. The aim of the study was to investigate antimullerian hormone (AMH) and inhibin B levels (sertoli cell markers) in obese boys and their relations to cardiovascular risk factors such as insulin sensitivity index, aortic intima media thickness (aIMT) and high sensitive c-reactive protein (hsCRP).

Patients, methods 121 obese and 38 healthy lean adolescents were included in the study. Serum AMH, inhibin B, gonadotropins, total testosterone, lipids, hsCRP, glucose and insulin levels were detected and analyzed. Insulin resistance was analyzed using the homeostasis model assessment (HOMA-IR). aIMT was measured by high-resolution B-mode ultrasonography.

Results Serum AMH, inhibin B and total testosterone levels were lower in the obese adolescents (p=0.01, p=0.009 and p=0.002, respectively). aIMT measurements (p<0.001, 0.63±0.09 and 0.47±0.06 mm, respectively) and hsCRP levels (p<0.001, 2.5±0.4 and 0.66±0.69 mg/L, respectively) were significantly increased in the obese group. Obese with IR group had decreased AMH levels (p=0.02, 53.0±20.5 and 66.7±19.5 ng/mL, respectively) and increased triglycerides, HOMA-IR, aIMT measurements than non-IR obese group. AMH levels were correlated negatively with body mass index (r:−0.108, p=0.03), HOMA-IR (r:−0.358, p=0.003) and fasting insulin levels (r:−0.389, p=0.001) in obese group with IR.

Conclusion We found that concentrations of both sertoli cell markers (AMH and inhibin B) were significantly lower in obese pubertal boys especially in obese with IR. Obesity and IR might be important factors for the sertoli cell impairment in pubertal boys.

 
  • References

  • 1 Aggerholm AS, Thulstrup AM, Toft G. et al. Is overweight a risk factor for reduced semen quality and altered serum sex hormone profile?. Fertil Steril 2008; 90: 619-626
  • 2 Jensen TK, Andersson A, Jørgensen N. et al. Body mass index in relation to semen quality and reproductive hormones among 1,558 Danish men. Fertil Steril 2004; 82: 863-870
  • 3 Qin D, Yuan W, Zhou W. et al. Do reproductive hormones explain the association between body mass index and semen quality?. Asian J Androl 2007; 9: 827-834
  • 4 Du Plessis SS, Cabler S, McAlister DA. et al. The effect of obesity on sperm disorders and male infertility. Nat Rev Urol 2010; 7: 153-161
  • 5 Pasquali R. Obesity and androgens: Facts and perspectives. Fertil Steril 2006; 85: 1319-1340
  • 6 Pasquali R, Patton L, Gambineri A. Obesity and infertility. Curr Opin Endocrinol Diabetes Obes 2007; 14: 482-487
  • 7 Traish AM, Guay A, Feeley R. et al. The dark side of testosterone deficiency: I. Metabolic syndrome and erectile dysfunction. J Androl 2009; 30: 10-22
  • 8 Boonstra VH, Weber RF, de Jong FH. et al. Testis function in prepubertal boys and young men born small for gestational age. Horm Res 2008; 70: 357-363
  • 9 Atanassova N, McKinnell C, Walker M. et al. Permanent effects of neonatal estrogen exposure in rats on reproductive hormone levels, sertoli cell number, and the efficiency of spermatogenesis in adulthood. Endocrinology 1999; 140: 5364-5373
  • 10 Lee MM, Donahoe PK, Hasegawa T. et al. Mullerian inhibiting substance in humans: normal levels from infancy to adulthood. J Clin Endocrinol Metab 1996; 81: 571-576
  • 11 Semercioz A, Baltaci AK, Mogulkoc R. et al. Effect of Zinc and melatonin on oxidative stress and serum inhibin-b levels in a rat testicular torsion-detorsion model. Biochem Genet 2017; 55: 395-409
  • 12 Robeva R, Tomova A, Kirilov G. et al. Anti-Müllerian hormone and inhibin B levels reflect altered Sertoli cell function in men with metabolic syndrome. Andrologia 2012; 44: 329-334
  • 13 Paasch U, Grunewald S, Kratzsch J. et al. Obesity and age affect male fertility potential. Fertil Steril 2010; 94: 2898-2901
  • 14 Keskin M, Kurtoglu S, Kendirci M. et al. Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents. Pediatrics 2005; 115: 500-503
  • 15 Tuttelmann F, Dykstra N, Themmen AP. et al. Anti-Mullerian hormone in men with normal and reduced sperm concentration and men with maldescended testes. Fertil Steril 2009; 91: 1812-1819
  • 16 Leisegang K, Bouic P, Menkveld R. et al. Obesity is associated with increased seminal insulin and leptin alongside reduced fertility parameters in a controlled male cohort. Reprod Biol Endocrinol 2014; 12: 34
  • 17 Tsai EC, Matsumoto AM, Fujimoto WY. et al. Association of bioavailable, free, and total testosterone with insulin resistance: Influence of sex hormone-binding globulin and body fat. Diabetes Care 2004; 27: 861-868
  • 18 Skałba P, Cygal A, Madej P. et al. Is the plasma anti-Müllerian hormone (AMH) level associated with body weight and metabolic, and hormonal disturbances in women with and without polycystic ovary syndrome?. Eur J Obstet Gynecol Reprod Biol 2011; 158: 254-259
  • 19 Piouka A, Farmakiotis D, Katsikis I. et al. Anti-Mullerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels. Am J Physiol Endocrinol Metab 2009; 296: 238-243
  • 20 Luca G, Calvitti M, Neri LM. et al. Sertoli cell-induced reversal of adult rat pancreatic islet beta-cells into fetal-like status: Potential implications for islet transplantation in type I diabetes mellitus. J Investig Med 2000; 48: 441-448
  • 21 Van Maldergem L, Bachy A, Feldman D. et al Syndrome of lipoatrophic diabetes, vitamin D resistant rickets, and persistent Mullerian ducts in a Turkish boy born to consanguineous parents. Am J Med Genet 1996; 64: 506-513
  • 22 Park HT, Cho GJ, Ahn KH. et al. Association of insulin resistance with anti-Mullerian hormone levels in women without polycystic ovary syndrome (PCOS). ClinEndocrinol (Oxf) 2010; 72: 26-31
  • 23 Nardo LG, Yates AP, Roberts SA. et al. The relationships between AMH, androgens, insulin resistance and basal ovarian follicular status in non-obese subfertile women with and without polycystic ovary syndrome. Hum Reprod 2009; 24: 2917-2923
  • 24 Winters SJ, Wang C, Abdelrahaman E. et al. Inhibin-B levels in healthy young adult men and prepubertal boys: is obesity the cause for the contemporary decline in sperm count because of fewer Sertoli cells?. J Androl 2006; 27: 560-564
  • 25 Chong YH, Dennis NA, Connolly MJ. et al. Elderly men have low levels of anti-Müllerian hormone and inhibin B, but with high interpersonal variation: a cross-sectional study of the sertoli cell hormones in 615 community-dwelling men. PLoS One 2013; 8: 70967